Zhan-Miao Yi (Zhanmiao Yi)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 13

Top Topics

Venous Thromboembolism

Systematic Review

Clinical Practice

Top Venues

Clinical pharmacokinetics

BMC public health

Therapeutic advances in medical oncology

CNS neuroscience & therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Yi Ma, Zaiwei Song, Xinya Li, Dan Jiang, Rongsheng Zhao, Zhan-Miao Yi
Toward Genetic Testing of Rivaroxaban? Insights from a Systematic Review on the Role of Genetic Polymorphism in Rivaroxaban Therapy. Clinical pharmacokinetics (2024)
Yi Ma, Zaiwei Song, Xinya Li, Dan Jiang, Rongsheng Zhao, Zhan-Miao Yi
Toward Genetic Testing of Rivaroxaban? Insights from a Systematic Review on the Role of Genetic Polymorphism in Rivaroxaban Therapy. Clinical pharmacokinetics 63 (3) (2024)
Xinya Li, Zaiwei Song, Zhan-Miao Yi, Jiguang Qin, Dan Jiang, Zhitong Wang, Huibo Li, Rongsheng Zhao
Therapeutic drug monitoring guidelines in oncology: what do we know and how to move forward? Insights from a systematic review. Therapeutic advances in medical oncology 16 (2024)
Xinya Li, Zaiwei Song, Zhan-Miao Yi, Jiguang Qin, Dan Jiang, Zhitong Wang, Huibo Li, Rongsheng Zhao
Therapeutic drug monitoring guidelines in oncology: what do we know and how to move forward? Insights from a systematic review. Therapeutic advances in medical oncology 16 (2024)
Zhan-Miao Yi, Yudan Mao, Chenxuan He, Yantao Zhang, Junwen Zhou, Xing Lin Feng
Medication adherence and costs of medical care among patients with Parkinson's disease: an observational study using electronic medical records. BMC public health 24 (1) (2024)
Yi Ma, Zaiwei Song, Xinya Li, Dan Jiang, Rongsheng Zhao, Zhan-Miao Yi
Toward Genetic Testing of Rivaroxaban? Insights from a Systematic Review on the Role of Genetic Polymorphism in Rivaroxaban Therapy. Clinical pharmacokinetics 63 (3) (2024)
Zhan-Miao Yi, Yudan Mao, Chenxuan He, Yantao Zhang, Junwen Zhou, Xing Lin Feng
Medication adherence and costs of medical care among patients with Parkinson's disease: an observational study using electronic medical records. BMC public health 24 (1) (2024)
Zhan-Miao Yi, Yudan Mao, Chenxuan He, Yantao Zhang, Junwen Zhou, Xing Lin Feng
Medication adherence and costs of medical care among patients with Parkinson's disease: an observational study using electronic medical records. BMC public health 24 (1) (2024)
Yi Ma, Zaiwei Song, Xinya Li, Dan Jiang, Rongsheng Zhao, Zhan-Miao Yi
Toward Genetic Testing of Rivaroxaban? Insights from a Systematic Review on the Role of Genetic Polymorphism in Rivaroxaban Therapy. Clinical pharmacokinetics 63 (3) (2024)
Zhan-Miao Yi, Xinya Li, Zhitong Wang, Jiguang Qin, Dan Jiang, Panhui Tian, Ping Yang, Rongsheng Zhao
Status and Quality of Guidelines for Therapeutic Drug Monitoring Based on AGREE II Instrument. Clinical pharmacokinetics (2023)
Qingli Meng, Hong-Yan Gu, Qinghua Zhang, Zhan-Miao Yi, Dechun Jiang
Carbamazepine cutaneous adverse reactions and HLA gene variation in the Chinese population: a systematic review and meta-analysis. Pharmacogenomics (2023)
Wenting Li, Hua Zhang, Yuan Zhang, Ke Wang, Jiaojiao Hui, Zhan-Miao Yi
Comparison of the effectiveness, safety, and costs of anti-Parkinson drugs: A multiple-center retrospective study. CNS neuroscience & therapeutics (2023)
Zhan-Miao Yi, Peng Men, Shuli Qu, Chaoyun Li, Xin Yu, Suodi Zhai
Comparative cost-effectiveness of amisulpride and olanzapine in the treatment of schizophrenia in China. Expert review of pharmacoeconomics & outcomes research 20 (3) (2020)